ea0029p1592 | Thyroid (non-cancer) | ICEECE2012
Maqdasy S.
, Batisse-Lignier M.
, Lusson J.
, Lamaison D.
, Citron B.
, Roche B.
, Desbiez F.
, Thieblot P.
, Tauveron I.
Introduction: Amiodarone-induced thyrotoxicosis (AIT) contributes to increased morbidity and mortality in patients invariably having underlying heart disease. In clinical practice, amiodarone therapy often needs to be restarted. When amiodarone is reintroduced, what happens then?Objective: The aim of study is to evaluate the progression of thyroid function after reinstitution of amiodarone in patients with a previous history of AIT. Secondarily, to deter...